Your privacy is very important for us. When you visit our website, please agree to the use of all cookies. For more information about the processing of personal data, please go to Privacy policy

com_logo.svg

MINHONG CAI

Associate
d1_1img08.jpg

Minhong Cai is an associate of the RuiMin team. Her primary practice areas include M&A, private equity and general corporate matters.


Prior to joining RuiMin, Minhong worked at the leading Chinese firm Fangda Partners for 2 years.

Minhong speaks fluent English, Mandarin and Cantonese.


  • Experience

    • Advising AstraZeneca on its US$1.2bn acquisition of Nasdaq-listed Gracell Biotechnology (ALB China 2024 M&A Deal of the Year Award)

    • Advising CVC Capital Partners on its acquisition of Scan Global Logistics (SGL), a global full-service logistics provider,with an enterprise value of US$1.67bn

    • Advising Ericsson (NASDAQ: ERIC) on the sale of its Internet of Things Accelerator (IoTA) and Connected Vehicle Cloud (CVC) businesses to Aeris Communications, Inc.

    • Advising Cainiao on its US$67m investment in De Well Group, a leading international freight forwarder

    • Advising Midea Group (000333.SZ) on its RMB2.3bn acquisition of the controlling stake of Wandong Medical (600055.SH)

    • Advising Lumentum Holdings Inc. (NASDAQ: LITE) on its US$918m acquisition of NeoPhotonics Corporation (NYSE:NPTN)

    • Advising Sandvik Machining Solutions AB on its acquisition of Suzhou Ahno Group, a group leading in the precision cutting tool industry of China

  • Qualifications

    Minhong graduated from China University of Political Science and Law where she obtained LLB and LLM degrees.